FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38617811000001107: Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jun 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1383451000001118 Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1383461000001115 Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Is a Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Is a Salbutamol+ipratropium bromide 2.5mg/500micrograms nebulization unit false Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Is a Combiprasal true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Has specific active ingredient Ipratropium bromide true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salbutamol true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Has dispensed dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Has specific active ingredient Salbutamol sulfate true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Is a Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) 60 unit dose 12 x 5 unit dose vials Has AMP True Combiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vials (TriOn Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start